Inventor
HALDER ARINDAM
IN15 patents
⚠️ This page may combine multiple inventors who share the name “HALDER ARINDAM”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SUN PHARMA ADVANCED RES CO LTD
12 patentsUS11058684B2Jul 13, 2021
Method of increasing bioavailability and/or prolonging ophthalmic action of a drug
SUN PHARMA ADVANCED RES CO LTD4 citations82
US10172852B2Jan 8, 2019
Method of increasing bioavailability and/or prolonging ophthalmic action of a drug
SUN PHARMA ADVANCED RES CO LTD5 citations82
US11951106B2Apr 9, 2024
Method of increasing bioavailability and/or prolonging ophthalmic action of a drug
SUN PHARMA ADVANCED RES CO LTD2 citations71
US11931359B2Mar 19, 2024
Method of increasing bioavailability and/or prolonging ophthalmic action of a drug
SUN PHARMA ADVANCED RES CO LTD2 citations71
US11890375B2Feb 6, 2024
Ophthalmic solution of difluprednate
SUN PHARMA ADVANCED RES CO LTD2 citations70
US11103451B2Aug 31, 2021
Ophthalmic solution of difluprednate
SUN PHARMA ADVANCED RES CO LTD3 citations70
US11000475B2May 11, 2021
Ophthalmic solution of difluprednate
SUN PHARMA ADVANCED RES CO LTD3 citations70
US12409175B2Sep 9, 2025
Method of increasing bioavailability and/or prolonging ophthalmic action of a drug
SUN PHARMA ADVANCED RES CO LTD0 citations61
US11241443B2Feb 8, 2022
Ophthalmic solution of bimatoprost
SUN PHARMA ADVANCED RES CO LTD0 citations61
US12383496B2Aug 12, 2025
Ophthalmic solution of difluprednate
SUN PHARMA ADVANCED RES CO LTD0 citations59
US11559487B2Jan 24, 2023
Drug loaded nanoresin particles
SUN PHARMA ADVANCED RES CO LTD0 citations55
US9539262B2Jan 10, 2017
Ophthalmic composition comprising a prostaglandin
SUN PHARMA ADVANCED RES CO LTD1 citations51